SC 13G/A | 2022-01-26 | BlackRock Inc. | Coherus BioSciences, Inc. | 11,918,855 | 15.5% | EDGAR |
SC 13G/A | 2022-01-07 | JPMORGAN CHASE & CO | Coherus BioSciences, Inc. | 6,355,187 | 8.2% | EDGAR |
SC 13G/A | 2021-02-16 | PERCEPTIVE ADVISORS LLC | Coherus BioSciences, Inc. | 4,671,836 | 6.5% | EDGAR |
SC 13G | 2021-02-10 | VANGUARD GROUP INC | Coherus BioSciences, Inc. | 4,128,935 | 5.7% | EDGAR |
SC 13G | 2021-02-08 | STATE STREET CORP | Coherus BioSciences, Inc. | - | 6.4% | EDGAR |
SC 13G | 2021-02-08 | ALLIANCEBERNSTEIN L.P. | Coherus BioSciences, Inc. | 4,704,200 | 6.5% | EDGAR |
SC 13G/A | 2021-01-26 | BlackRock Inc. | Coherus BioSciences, Inc. | 10,528,350 | 14.6% | EDGAR |
SC 13G | 2021-01-08 | JPMORGAN CHASE & CO | Coherus BioSciences, Inc. | 4,962,682 | 6.8% | EDGAR |
SC 13G | 2020-10-07 | PERCEPTIVE ADVISORS LLC | Coherus BioSciences, Inc. | 3,586,485 | 5.0% | EDGAR |
SC 13G/A | 2020-06-09 | BlackRock Inc. | Coherus BioSciences, Inc. | 10,158,999 | 14.3% | EDGAR |
SC 13G/A | 2020-02-07 | Temasek Holdings (Private) Ltd | Coherus BioSciences, Inc. | 7,381,116 | 10.5% | EDGAR |
SC 13G/A | 2020-02-05 | BlackRock Inc. | Coherus BioSciences, Inc. | 5,672,219 | 8.1% | EDGAR |
SC 13G/A | 2020-01-10 | FMR LLC | Coherus BioSciences, Inc. | 950,800 | 1.4% | EDGAR |
SC 13G/A | 2020-01-06 | JPMORGAN CHASE & CO | Coherus BioSciences, Inc. | 3,467,754 | 4.9% | EDGAR |
SC 13D/A | 2019-12-02 | KKR Fund Holdings L.P. | Coherus BioSciences, Inc. | 3,949,829 | 5.6% | EDGAR |
SC 13G/A | 2019-11-08 | WELLINGTON MANAGEMENT GROUP LLP | Coherus BioSciences, Inc. | 2,366,467 | 3.4% | EDGAR |
SC 13G/A | 2019-02-14 | HEALTHCARE ROYALTY PARTNERS III, L.P. | Coherus BioSciences, Inc. | 1,677,701 | 2.4% | EDGAR |
SC 13G/A | 2019-02-13 | FMR LLC | Coherus BioSciences, Inc. | 4,580,229 | 6.7% | EDGAR |
SC 13G/A | 2019-02-13 | Daiichi Sankyo Company, LTD | Coherus BioSciences, Inc. | 0 | 0.0% | EDGAR |
SC 13G/A | 2019-02-12 | WELLINGTON MANAGEMENT GROUP LLP | Coherus BioSciences, Inc. | 7,663,457 | 11.3% | EDGAR |